✦ LIBER ✦

The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

✍ Scribed by Ma'anit Shapira, Eli Kakiashvili, Tzur Rosenberg, Dan D Hershko

Book ID: 120700206
Publisher: BioMed Central
Year: 2006
Tongue: English
Weight: 684 KB
Volume: 8
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr1533

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The mTOR inhibitor rapamycin stabilizes

The mTOR inhibitor rapamycin stabilizes p27 by downregulating the expression of its ubiquitin ligase Skp2 in breast cancer

✍ D. Hershko; Kakiashvili; Z. Rosenberg; M. Shapira 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 268 KB

The mTOR inhibitor rapamycin inhibits p2

The mTOR inhibitor rapamycin inhibits p27 protein degradation by downregulating the expression of its ubiquitin ligase Skp2 in breast cancer

✍ Dan D. Hershko; Eli Kakiashvili; Zur Rosenberg; Ma’anit Shapira 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

P13 Differential effects of doxorubicin

P13 Differential effects of doxorubicin treatment on the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

✍ D. Hershk; O. Bar On; M. Shapira 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Resveratrol enhances the anti-tumor acti

Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling

✍ Xin He; Yu Wang; Jinhong Zhu; Mohammed Orloff; Charis Eng 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 854 KB

The degradation of cell cycle regulators

The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease

✍ Diego F. Calvisi; Federico Pinna; Sara Ladu; Maria R. Muroni; Maddalena Frau; Il 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 560 KB

## Abstract Previous work showed a genetic control of cell cycle deregulation during hepatocarcinogenesis. We now evaluated in preneoplastic lesions, dysplastic nodules and hepatocellular carcinoma (HCC), chemically induced in genetically susceptible F344 and resistant Brown Norway (BN) rats, the r

Rapamycin inhibits the invasive ability

Rapamycin inhibits the invasive ability of thyroid cancer cells by down-regulating the expression of VEGF-C in vitro

✍ Wenli Feng; Shenshan Jia 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB